CHC Healthcare Group (4164) - Total Liabilities

Latest as of September 2025: NT$6.86 Billion TWD ≈ $216.00 Million USD

Based on the latest financial reports, CHC Healthcare Group (4164) has total liabilities worth NT$6.86 Billion TWD (≈ $216.00 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 4164 cash flow conversion to assess how effectively this company generates cash.

CHC Healthcare Group - Total Liabilities Trend (2009–2024)

This chart illustrates how CHC Healthcare Group's total liabilities have evolved over time, based on quarterly financial data. Check CHC Healthcare Group liquid asset ratio to evaluate the company's liquid asset resilience ratio.

CHC Healthcare Group Competitors by Total Liabilities

The table below lists competitors of CHC Healthcare Group ranked by their total liabilities.

Company Country Total Liabilities
Franklin Covey Company
NYSE:FC
USA $167.25 Million
Parrot
PA:PARRO
France €36.60 Million
Vina San Pedro
SN:VSPT
Chile CL$159.71 Billion
Dynamix Corporation
NASDAQ:ETHM
USA $27.35 Million
NOVAREX Co.Ltd
KQ:194700
Korea ₩104.91 Billion
FineTek Co Ltd
TWO:4549
Taiwan NT$781.20 Million
Wei Chih Steel Industrial Co Ltd
TW:2028
Taiwan NT$3.74 Billion
TIDEWATER RENEWABLES LTD
F:7GZ
Germany €242.40 Million

Liability Composition Analysis (2009–2024)

This chart breaks down CHC Healthcare Group's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 4164 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.91 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.46 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how CHC Healthcare Group's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for CHC Healthcare Group (2009–2024)

The table below shows the annual total liabilities of CHC Healthcare Group from 2009 to 2024.

Year Total Liabilities Change
2024-12-31 NT$7.51 Billion
≈ $236.59 Million
+9.82%
2023-12-31 NT$6.84 Billion
≈ $215.43 Million
+6.38%
2022-12-31 NT$6.43 Billion
≈ $202.51 Million
+2.79%
2021-12-31 NT$6.25 Billion
≈ $197.02 Million
+12.80%
2020-12-31 NT$5.54 Billion
≈ $174.66 Million
-5.85%
2019-12-31 NT$5.89 Billion
≈ $185.50 Million
+3.04%
2018-12-31 NT$5.71 Billion
≈ $180.03 Million
+0.63%
2017-12-31 NT$5.68 Billion
≈ $178.90 Million
+17.96%
2016-12-31 NT$4.81 Billion
≈ $151.67 Million
+10.90%
2015-12-31 NT$4.34 Billion
≈ $136.76 Million
+48.62%
2014-12-31 NT$2.92 Billion
≈ $92.02 Million
+32.10%
2013-12-31 NT$2.21 Billion
≈ $69.66 Million
-22.17%
2012-12-31 NT$2.84 Billion
≈ $89.51 Million
+11.38%
2011-12-31 NT$2.55 Billion
≈ $80.36 Million
+43.62%
2010-12-31 NT$1.78 Billion
≈ $55.95 Million
-8.85%
2009-12-31 NT$1.95 Billion
≈ $61.39 Million
--

About CHC Healthcare Group

TW:4164 Taiwan Medical Distribution
Market Cap
$178.76 Million
NT$5.67 Billion TWD
Market Cap Rank
#16960 Global
#840 in Taiwan
Share Price
NT$29.05
Change (1 day)
-1.36%
52-Week Range
NT$29.05 - NT$51.70
All Time High
NT$73.80
About

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitatio… Read more